CIDP Clinical Trials CIDP RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Condition:   Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Intervention:   Drug: Rozanolixizumab Sponsor:   UCB Biopharma S.P.R.L. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2019 Category: Research Source Type: clinical trials